SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-027722
Filing Date
2024-02-26
Accepted
2024-02-26 20:04:11
Documents
2
Period of Report
2024-02-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm247229-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm247229-2_3seq1.xml 3 1628
2 EXHIBIT 24 tm247229d2_ex24.htm EX-24 8000
  Complete submission text file 0001104659-24-027722.txt   11149
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Issuer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AERPIO PHARMACEUTICALS, INC. 9987 CARVER ROAD CINCINNATI OH 45242
Business Address
Dugel Pravin (Reporting) CIK: 0001700917 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36554 | Film No.: 24681388